DR. ALEXANDER K STEWART, M.D.
Osteopathic Medicine at Shea Blvd, Scottsdale, AZ
License number
Arizona 34437
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
13400 E Shea Blvd, Scottsdale, AZ 85259
Phone
(480) 301-8000
Professional information
Dr. Alexander K Stewart, Scottsdale AZ - MD (Doctor of Medicine)
Specialties:
Hematology
Address:
Mayo Clinic Scottsdale
13400 E Shea Blvd, Scottsdale 85259
(480) 301-8000 (Phone)
Mayo Clinic
13400 E Shea Blvd, Scottsdale 85259
(480) 301-8000 (Phone)
13400 E Shea Blvd, Scottsdale 85259
(480) 301-8000 (Phone)
Mayo Clinic
13400 E Shea Blvd, Scottsdale 85259
(480) 301-8000 (Phone)
Languages:
English
Hospitals:
Mayo Clinic Scottsdale
13400 E Shea Blvd, Scottsdale 85259
Mayo Clinic
13400 E Shea Blvd, Scottsdale 85259
Mayo Clinic Hospital
5777 East Mayo Blvd, Phoenix 85054
13400 E Shea Blvd, Scottsdale 85259
Mayo Clinic
13400 E Shea Blvd, Scottsdale 85259
Mayo Clinic Hospital
5777 East Mayo Blvd, Phoenix 85054
Methods And Materials For Assessing Responsiveness To Lenalidomide, Thalidomide, And/Or Other Thalidomide Analogs
US Patent:
2014006, Mar 6, 2014
Filed:
Mar 8, 2012
Appl. No.:
14/003622
Inventors:
Alexander Keith Stewart - Scottsdale AZ, US
Peter Bergsagel - Scottsdale AZ, US
Rafael Fonseca - Scottsdale AZ, US
Esteban Braggio - Scottsdale AZ, US
Peter Bergsagel - Scottsdale AZ, US
Rafael Fonseca - Scottsdale AZ, US
Esteban Braggio - Scottsdale AZ, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
A61K 31/454
US Classification:
514323
Abstract:
This document provides methods and materials related to assessing responsiveness to lenalidomide, thalidomide, and/or other IMiDs (structural and functional analogues of thalidomide that represent a promising new class of immunomodulators). For example, methods and materials for using CRBN levels to determine whether or not cancer cells (e.g., multiple myeloma cells) are susceptible to lenalidomide, thalidomide, and/or other IMiDs are provided.
Inhibiting Cyclin D Polypeptides
US Patent:
2010014, Jun 10, 2010
Filed:
Oct 10, 2007
Appl. No.:
12/445065
Inventors:
Rodger E. Tiedemann - Scottsdale AZ, US
Alexander Keith Stewart - Scottsdale AZ, US
Aaron David Schimmer - Thornhill, CA
Xinliang Mao - Markham, CA
Alexander Keith Stewart - Scottsdale AZ, US
Aaron David Schimmer - Thornhill, CA
Xinliang Mao - Markham, CA
International Classification:
A61K 31/573, C12N 5/02, C12N 5/077, A61K 31/12, A61K 31/35, A61K 31/52, A61K 31/19
US Classification:
514171, 435375, 4353721, 514691, 514460, 51426323, 514569
Abstract:
This document involves methods and materials related to inhibiting cyclin D polypeptide activity. For example, this document provides methods and materials that can be used to (1) identify mammals or cells in need of cyclin D polypeptide inhibition and (2) administer an agent capable of inhibiting cyclin D polypeptide activity.
Treating Multiple Myeloma
US Patent:
2013028, Oct 24, 2013
Filed:
Dec 22, 2011
Appl. No.:
13/995623
Inventors:
Rafael Fonseca - Scottsdale AZ, US
Alexander Keith Stewart - Scottsdale AZ, US
Peter Bergsagel - Scottsdale AZ, US
Marta Chesi - Scottsdale AZ, US
Alexander Keith Stewart - Scottsdale AZ, US
Peter Bergsagel - Scottsdale AZ, US
Marta Chesi - Scottsdale AZ, US
Assignee:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH - Rochester MN
International Classification:
A61K 47/48
US Classification:
514 152
Abstract:
This document relates to methods and materials for treating multiple myeloma. For example, methods and materials for using albumin-bound paclitaxel composition (e.g., Abraxane®, a paclitaxel albumin-stabilized nanoparticle formulation) to treat multiple myeloma are provided.